These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21604493)

  • 1. [PLA-O-CMC nanoparticles: HGF loading and delivery behaviors in vitro].
    Li Z; Chen Z; Chang R
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):314-7. PubMed ID: 21604493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of HGF-loaded nanoparticles in treating rat acute hepatic failure.
    Chang RA; Chen Z; Li ZF
    Hepatogastroenterology; 2013 Oct; 60(127):1720-5. PubMed ID: 24634942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation and in vitro evaluation of brucine-loaded polylacticacid nanoparticles].
    Zhao J; Liu Z; Xu J; Yu Y; Feng N
    Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(18):2322-4. PubMed ID: 20030079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation.
    Jeevitha D; Amarnath K
    Colloids Surf B Biointerfaces; 2013 Jan; 101():126-34. PubMed ID: 22796782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.
    Wang W; Chen S; Zhang L; Wu X; Wang J; Chen JF; Le Y
    Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():514-20. PubMed ID: 25492016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced anti-topoisomerase II activity by mucoadhesive 4-CBS-chitosan/poly (lactic acid) nanoparticles.
    Songsurang K; Suvannasara P; Phurat C; Puthong S; Siraleartmukul K; Muangsin N
    Carbohydr Polym; 2013 Nov; 98(2):1335-42. PubMed ID: 24053811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.
    Essa S; Louhichi F; Raymond M; Hildgen P
    J Microencapsul; 2013; 30(3):205-17. PubMed ID: 22894166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.
    Zhang X; Liu L; Chai G; Zhang X; Li F
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1618-24. PubMed ID: 24087853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on chitosan-modified tripterygium glycoside nanoparticles and its renal targeting property].
    Chen XK; Wei YH; Yao JN; Zhao YM; Shang XG; Li FZ
    Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):548-52. PubMed ID: 23713281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
    Chen J; Tian B; Yin X; Zhang Y; Hu D; Hu Z; Liu M; Pan Y; Zhao J; Li H; Hou C; Wang J; Zhang Y
    J Biotechnol; 2007 Jun; 130(2):107-13. PubMed ID: 17467097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin delivery.
    Xiong XY; Li QH; Li YP; Guo L; Li ZL; Gong YC
    Colloids Surf B Biointerfaces; 2013 Nov; 111():282-8. PubMed ID: 23838194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Layer-by-layer assembly of poly(lactic acid) nanoparticles: a facile way to fabricate films for model drug delivery.
    Jiao YH; Li Y; Wang S; Zhang K; Jia YG; Fu Y
    Langmuir; 2010 Jun; 26(11):8270-3. PubMed ID: 20426432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and toxicity of triptolide-loaded poly (D,L-lactic acid) nanoparticles].
    Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
    Yao Xue Xue Bao; 2004 Jul; 39(7):556-60. PubMed ID: 15493850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
    Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
    Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic effects of aflatoxin B1 on embryonic development of zebrafish (Danio rerio): potential activity of piceatannol encapsulated chitosan/poly (lactic acid) nanoparticles.
    Dhanapal J; Ravindrran MB; Baskar SK
    Anticancer Agents Med Chem; 2015; 15(2):248-57. PubMed ID: 25322988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(lactic acid)/N-maleoylchitosan core-shell capsules: preparation and drug release properties.
    Zhu A; Li F; Ji L
    Colloids Surf B Biointerfaces; 2012 Mar; 91():162-7. PubMed ID: 22100385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
    Sheng Y; He H; Zou H
    Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and characterization of chitosan-polylacticacid-polyethylene glycol-gelatin nanoparticles: a novel biosystem for controlled drug delivery.
    Rajan M; Raj V
    Carbohydr Polym; 2013 Oct; 98(1):951-8. PubMed ID: 23987433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
    Essa S; Rabanel JM; Hildgen P
    Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.